Recall Register

Food, drugs, devices › Medtronic Perfusion Systems

Device recall: Medtronic DLP One-Piece Pediatric Arterial Cannula, Product Number/CFN 77010; Cardiopulmonary bypass vascular cannula

FDA enforcement event 99199 · Class II · initiated 25 May 2026 · status Ongoing

DeviceVoluntary: Firm initiated2 product recordsBrooklyn Park, MN

Medtronic Perfusion Systems (Brooklyn Park, MN) initiated this device recall on 25 May 2026; FDA lists 2 product records under event 99199, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 87% of the 572 device enforcement events initiated in 2026 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Medtronic Perfusion Systems has 38 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Medtronic Perfusion Systems, Brooklyn Park, MN.

Reason for recall

"Medtronic received two complaints of loose foreign material confirmed as containing trace levels of blood."

Distribution

"Worldwide - US Nationwide distribution in the states of MD, CA, MI, WA, PA, NC, FL, AR."

Product records

Recall numberProductQuantityClassStatusReport date
Z-2738-2026Medtronic DLP One-Piece Pediatric Arterial Cannula, Product Number/CFN 77010; Cardiopulmonary bypass vascular cannula—Class IIOngoing22 Jul 2026
Z-2739-2026Medtronic Bio-Medicus Adult Cannula Kit, Product Number/CFN 96530-115; Cardiopulmonary bypass vascular cannula—Class IIOngoing22 Jul 2026

Context

87%of 2026 device events are Class II572 events that year
2product records in this eventfirm median: 1
38events on this register for the firm

Other enforcement events for Medtronic Perfusion Systems

InitiatedProduct (first record)TypeClassRecords
24 Jun 2026EOPA Elongated One-Piece Arterial Cannula BLUNT 22FR, intended for use with cardiopulmonary bypass as an arterial returnDeviceClass II6
12 May 2026Octopus Evolution Tissue Stabilizer, Model TS2000DeviceClass II3
21 Apr 2026Medtronic GUNDRY Retrograde Cannula Manual-Inflate Silicone Body 13FR, Model 94113T; Cardiopulmonary bypass vascular catDeviceClass II9
13 Jan 2026Octopus Nuvo Tissue Stabilizer, disposable tissue stabilization system, Product Number TSMICS1DeviceClass II1
20 Oct 2025Medtronic HR-ACT (High Range Activated Clotting Time Cartridges), REF 402-03DeviceClass II1
3 Oct 2025MC3 VitalFlow Console, REF 58100; Blood pump of ecmoDeviceClass II1
12 Sep 2025Affinity NT Oxygenator, Oxygenator with Balance Biosurface and Uncoated Cardiotomy/Venous Reservoir, Product Number 541BDeviceClass II1
6 Aug 2025DLP Left Heart Vent Catheter Malleable body and vented connector, SUCTION 12113 LV VENT 13FR, Model Number 12113DeviceClass I3
5 Feb 2025Aortic Root Cannula: 1. DLP Aortic Root Cannula A. CANNULA 11012 AR FLOWGUARD 12GA, model no 11012 B. CANNULA 11014 AR FDeviceClass I1
12 Dec 2024DLP Pediatric One-Piece Arterial Cannulae, Model Numbers 77008 (8 Fr) and 77014 (14 Fr)DeviceClass II3

All 38 events for Medtronic Perfusion Systems

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Medtronic received two complaints of loose foreign material confirmed as containing trace levels of blood."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide - US Nationwide distribution in the states of MD, CA, MI, WA, PA, NC, FL, AR."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.